Similar outcomes were observed in HT-29-derived spheroids (Fig. 7H, I), strongly indicating that USP11 may serve as a promising therapeutic target for the intervention in EGFR- or TLR-driven CRC formation. This evidence concerns the gene USP11 and colorectal carcinoma.